Display options
Cite
Zhang H, Ahearn TU, Lecarpentier J, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52(6):572-581doi: 10.1038/s41588-020-0609-2.
Zhang, H., Ahearn, T. U., Lecarpentier, J., Barnes, D., Beesley, J., Qi, G., Jiang, X., O'Mara, T. A., Zhao, N., Bolla, M. K., Dunning, A. M., Dennis, J., Wang, Q., Ful, Z. A., Aittomäki, K., Andrulis, I. L., Anton-Culver, H., Arndt, V., Aronson, K. J., Arun, B. K., Auer, P. L., Azzollini, J., Barrowdale, D., Becher, H., Beckmann, M. W., Behrens, S., Benitez, J., Bermisheva, M., Bialkowska, K., Blanco, A., Blomqvist, C., Bogdanova, N. V., Bojesen, S. E., Bonanni, B., Bondavalli, D., Borg, A., Brauch, H., Brenner, H., Briceno, I., Broeks, A., Brucker, S. Y., Brüning, T., Burwinkel, B., Buys, S. S., Byers, H., Caldés, T., Caligo, M. A., Calvello, M., Campa, D., Castelao, J. E., Chang-Claude, J., Chanock, S. J., Christiaens, M., Christiansen, H., Chung, W. K., Claes, K. B. M., Clarke, C. L., Cornelissen, S., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Daly, M. B., Devilee, P., Diez, O., Domchek, S. M., Dörk, T., Dwek, M., Eccles, D. M., Ekici, A. B., Evans, D. G., Fasching, P. A., Figueroa, J., Foretova, L., Fostira, F., Friedman, E., Frost, D., Gago-Dominguez, M., Gapstur, S. M., Garber, J., García-Sáenz, J. A., Gaudet, M. M., Gayther, S. A., Giles, G. G., Godwin, A. K., Goldberg, M. S., Goldgar, D. E., González-Neira, A., Greene, M. H., Gronwald, J., Guénel, P., Häberle, L., Hahnen, E., Haiman, C. A., Hake, C. R., Hall, P., Hamann, U., Harkness, E. F., Heemskerk-Gerritsen, B. A. M., Hillemanns, P., Hogervorst, F. B. L., Holleczek, B., Hollestelle, A., Hooning, M. J., Hoover, R. N., Hopper, J. L., Howell, A., Huebner, H., Hulick, P. J., Imyanitov, E. N., Isaacs, C., Izatt, L., Jager, A., Jakimovska, M., Jakubowska, A., James, P., Janavicius, R., Janni, W., John, E. M., Jones, M. E., Jung, A., Kaaks, R., Kapoor, P. M., Karlan, B. Y., Keeman, R., Khan, S., Khusnutdinova, E., Kitahara, C. M., Ko, Y. D., Konstantopoulou, I., Koppert, L. B., Koutros, S., Kristensen, V. N., Laenkholm, A. V., Lambrechts, D., Larsson, S. C., Laurent-Puig, P., Lazaro, C., Lazarova, E., Lejbkowicz, F., Leslie, G., Lesueur, F., Lindblom, A., Lissowska, J., Lo, W. Y., Loud, J. T., Lubinski, J., Lukomska, A., MacInnis, R. J., Mannermaa, A., Manoochehri, M., Manoukian, S., Margolin, S., Martinez, M. E., Matricardi, L., McGuffog, L., McLean, C., Mebirouk, N., Meindl, A., Menon, U., Miller, A., Mingazheva, E., Montagna, M., Mulligan, A. M., Mulot, C., Muranen, T. A., Nathanson, K. L., Neuhausen, S. L., Nevanlinna, H., Neven, P., Newman, W. G., Nielsen, F. C., Nikitina-Zake, L., Nodora, J., Offit, K., Olah, E., Olopade, O. I., Olsson, H., Orr, N., Papi, L., Papp, J., Park-Simon, T. W., Parsons, M. T., Peissel, B., Peixoto, A., Peshkin, B., Peterlongo, P., Peto, J., Phillips, K. A., Piedmonte, M., Plaseska-Karanfilska, D., Prajzendanc, K., Prentice, R., Prokofyeva, D., Rack, B., Radice, P., Ramus, S. J., Rantala, J., Rashid, M. U., Rennert, G., Rennert, H. S., Risch, H. A., Romero, A., Rookus, M. A., Rübner, M., Rüdiger, T., Saloustros, E., Sampson, S., Sandler, D. P., Sawyer, E. J., Scheuner, M. T., Schmutzler, R. K., Schneeweiss, A., Schoemaker, M. J., Schöttker, B., Schürmann, P., Senter, L., Sharma, P., Sherman, M. E., Shu, X. O., Singer, C. F., Smichkoska, S., Soucy, P., Southey, M. C., Spinelli, J. J., Stone, J., Stoppa-Lyonnet, D., Swerdlow, A. J., Szabo, C. I., Tamimi, R. M., Tapper, W. J., Taylor, J. A., Teixeira, M. R., Terry, M., Thomassen, M., Thull, D. L., Tischkowitz, M., Toland, A. E., Tollenaar, R. A. E. M., Tomlinson, I., Torres, D., Troester, M. A., Truong, T., Tung, N., Untch, M., Vachon, C. M., van den Ouweland, A. M. W., van der Kolk, L. E., van Veen, E. M., vanRensburg, E. J., Vega, A., Wappenschmidt, B., Weinberg, C. R., Weitzel, J. N., Wildiers, H., Winqvist, R., Wolk, A., Yang, X. R., Yannoukakos, D., Zheng, W., Zorn, K. K., Milne, R. L., Kraft, P., Simard, J., Pharoah, P. D. P., Michailidou, K., Antoniou, A. C., Schmidt, M. K., Chenevix-Trench, G., Easton, D. F., Chatterjee, N., & García-Closas, M. (2020). Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature genetics, 52(6), 572-581. https://doi.org/10.1038/s41588-020-0609-2
Zhang, Haoyu, et al. "Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses." Nature genetics vol. 52,6 (2020): 572-581. doi: https://doi.org/10.1038/s41588-020-0609-2
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Arun BK, Auer PL, Azzollini J, Barrowdale D, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bialkowska K, Blanco A, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Bondavalli D, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brucker SY, Brüning T, Burwinkel B, Buys SS, Byers H, Caldés T, Caligo MA, Calvello M, Campa D, Castelao JE, Chang-Claude J, Chanock SJ, Christiaens M, Christiansen H, Chung WK, Claes KBM, Clarke CL, Cornelissen S, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Diez O, Domchek SM, Dörk T, Dwek M, Eccles DM, Ekici AB, Evans DG, Fasching PA, Figueroa J, Foretova L, Fostira F, Friedman E, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, García-Sáenz JA, Gaudet MM, Gayther SA, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Gronwald J, Guénel P, Häberle L, Hahnen E, Haiman CA, Hake CR, Hall P, Hamann U, Harkness EF, Heemskerk-Gerritsen BAM, Hillemanns P, Hogervorst FBL, Holleczek B, Hollestelle A, Hooning MJ, Hoover RN, Hopper JL, Howell A, Huebner H, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Jager A, Jakimovska M, Jakubowska A, James P, Janavicius R, Janni W, John EM, Jones ME, Jung A, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khan S, Khusnutdinova E, Kitahara CM, Ko YD, Konstantopoulou I, Koppert LB, Koutros S, Kristensen VN, Laenkholm AV, Lambrechts D, Larsson SC, Laurent-Puig P, Lazaro C, Lazarova E, Lejbkowicz F, Leslie G, Lesueur F, Lindblom A, Lissowska J, Lo WY, Loud JT, Lubinski J, Lukomska A, MacInnis RJ, Mannermaa A, Manoochehri M, Manoukian S, Margolin S, Martinez ME, Matricardi L, McGuffog L, McLean C, Mebirouk N, Meindl A, Menon U, Miller A, Mingazheva E, Montagna M, Mulligan AM, Mulot C, Muranen TA, Nathanson KL, Neuhausen SL, Nevanlinna H, Neven P, Newman WG, Nielsen FC, Nikitina-Zake L, Nodora J, Offit K, Olah E, Olopade OI, Olsson H, Orr N, Papi L, Papp J, Park-Simon TW, Parsons MT, Peissel B, Peixoto A, Peshkin B, Peterlongo P, Peto J, Phillips KA, Piedmonte M, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Prokofyeva D, Rack B, Radice P, Ramus SJ, Rantala J, Rashid MU, Rennert G, Rennert HS, Risch HA, Romero A, Rookus MA, Rübner M, Rüdiger T, Saloustros E, Sampson S, Sandler DP, Sawyer EJ, Scheuner MT, Schmutzler RK, Schneeweiss A, Schoemaker MJ, Schöttker B, Schürmann P, Senter L, Sharma P, Sherman ME, Shu XO, Singer CF, Smichkoska S, Soucy P, Southey MC, Spinelli JJ, Stone J, Stoppa-Lyonnet D, Swerdlow AJ, Szabo CI, Tamimi RM, Tapper WJ, Taylor JA, Teixeira MR, Terry M, Thomassen M, Thull DL, Tischkowitz M, Toland AE, Tollenaar RAEM, Tomlinson I, Torres D, Troester MA, Truong T, Tung N, Untch M, Vachon CM, van den Ouweland AMW, van der Kolk LE, van Veen EM, vanRensburg EJ, Vega A, Wappenschmidt B, Weinberg CR, Weitzel JN, Wildiers H, Winqvist R, Wolk A, Yang XR, Yannoukakos D, Zheng W, Zorn KK, Milne RL, Kraft P, Simard J, Pharoah PDP, Michailidou K, Antoniou AC, Schmidt MK, Chenevix-Trench G, Easton DF, Chatterjee N, García-Closas M. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020 Jun;52(6):572-581. doi: 10.1038/s41588-020-0609-2. Epub 2020 May 18. PMID: 32424353; PMCID: PMC7808397.
Copy Download .nbib Format: NLM
Share it on

Nat Genet. 2020 Jun;52(6):572-581. doi: 10.1038/s41588-020-0609-2. Epub 2020 May 18.

Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses.

Nature genetics

Haoyu Zhang, Thomas U Ahearn, Julie Lecarpentier, Daniel Barnes, Jonathan Beesley, Guanghao Qi, Xia Jiang, Tracy A O'Mara, Ni Zhao, Manjeet K Bolla, Alison M Dunning, Joe Dennis, Qin Wang, Zumuruda Abu Ful, Kristiina Aittomäki, Irene L Andrulis, Hoda Anton-Culver, Volker Arndt, Kristan J Aronson, Banu K Arun, Paul L Auer, Jacopo Azzollini, Daniel Barrowdale, Heiko Becher, Matthias W Beckmann, Sabine Behrens, Javier Benitez, Marina Bermisheva, Katarzyna Bialkowska, Ana Blanco, Carl Blomqvist, Natalia V Bogdanova, Stig E Bojesen, Bernardo Bonanni, Davide Bondavalli, Ake Borg, Hiltrud Brauch, Hermann Brenner, Ignacio Briceno, Annegien Broeks, Sara Y Brucker, Thomas Brüning, Barbara Burwinkel, Saundra S Buys, Helen Byers, Trinidad Caldés, Maria A Caligo, Mariarosaria Calvello, Daniele Campa, Jose E Castelao, Jenny Chang-Claude, Stephen J Chanock, Melissa Christiaens, Hans Christiansen, Wendy K Chung, Kathleen B M Claes, Christine L Clarke, Sten Cornelissen, Fergus J Couch, Angela Cox, Simon S Cross, Kamila Czene, Mary B Daly, Peter Devilee, Orland Diez, Susan M Domchek, Thilo Dörk, Miriam Dwek, Diana M Eccles, Arif B Ekici, D Gareth Evans, Peter A Fasching, Jonine Figueroa, Lenka Foretova, Florentia Fostira, Eitan Friedman, Debra Frost, Manuela Gago-Dominguez, Susan M Gapstur, Judy Garber, José A García-Sáenz, Mia M Gaudet, Simon A Gayther, Graham G Giles, Andrew K Godwin, Mark S Goldberg, David E Goldgar, Anna González-Neira, Mark H Greene, Jacek Gronwald, Pascal Guénel, Lothar Häberle, Eric Hahnen, Christopher A Haiman, Christopher R Hake, Per Hall, Ute Hamann, Elaine F Harkness, Bernadette A M Heemskerk-Gerritsen, Peter Hillemanns, Frans B L Hogervorst, Bernd Holleczek, Antoinette Hollestelle, Maartje J Hooning, Robert N Hoover, John L Hopper, Anthony Howell, Hanna Huebner, Peter J Hulick, Evgeny N Imyanitov, Claudine Isaacs, Louise Izatt, Agnes Jager, Milena Jakimovska, Anna Jakubowska, Paul James, Ramunas Janavicius, Wolfgang Janni, Esther M John, Michael E Jones, Audrey Jung, Rudolf Kaaks, Pooja Middha Kapoor, Beth Y Karlan, Renske Keeman, Sofia Khan, Elza Khusnutdinova, Cari M Kitahara, Yon-Dschun Ko, Irene Konstantopoulou, Linetta B Koppert, Stella Koutros, Vessela N Kristensen, Anne-Vibeke Laenkholm, Diether Lambrechts, Susanna C Larsson, Pierre Laurent-Puig, Conxi Lazaro, Emilija Lazarova, Flavio Lejbkowicz, Goska Leslie, Fabienne Lesueur, Annika Lindblom, Jolanta Lissowska, Wing-Yee Lo, Jennifer T Loud, Jan Lubinski, Alicja Lukomska, Robert J MacInnis, Arto Mannermaa, Mehdi Manoochehri, Siranoush Manoukian, Sara Margolin, Maria Elena Martinez, Laura Matricardi, Lesley McGuffog, Catriona McLean, Noura Mebirouk, Alfons Meindl, Usha Menon, Austin Miller, Elvira Mingazheva, Marco Montagna, Anna Marie Mulligan, Claire Mulot, Taru A Muranen, Katherine L Nathanson, Susan L Neuhausen, Heli Nevanlinna, Patrick Neven, William G Newman, Finn C Nielsen, Liene Nikitina-Zake, Jesse Nodora, Kenneth Offit, Edith Olah, Olufunmilayo I Olopade, Håkan Olsson, Nick Orr, Laura Papi, Janos Papp, Tjoung-Won Park-Simon, Michael T Parsons, Bernard Peissel, Ana Peixoto, Beth Peshkin, Paolo Peterlongo, Julian Peto, Kelly-Anne Phillips, Marion Piedmonte, Dijana Plaseska-Karanfilska, Karolina Prajzendanc, Ross Prentice, Darya Prokofyeva, Brigitte Rack, Paolo Radice, Susan J Ramus, Johanna Rantala, Muhammad U Rashid, Gad Rennert, Hedy S Rennert, Harvey A Risch, Atocha Romero, Matti A Rookus, Matthias Rübner, Thomas Rüdiger, Emmanouil Saloustros, Sarah Sampson, Dale P Sandler, Elinor J Sawyer, Maren T Scheuner, Rita K Schmutzler, Andreas Schneeweiss, Minouk J Schoemaker, Ben Schöttker, Peter Schürmann, Leigha Senter, Priyanka Sharma, Mark E Sherman, Xiao-Ou Shu, Christian F Singer, Snezhana Smichkoska, Penny Soucy, Melissa C Southey, John J Spinelli, Jennifer Stone, Dominique Stoppa-Lyonnet, Anthony J Swerdlow, Csilla I Szabo, Rulla M Tamimi, William J Tapper, Jack A Taylor, Manuel R Teixeira, MaryBeth Terry, Mads Thomassen, Darcy L Thull, Marc Tischkowitz, Amanda E Toland, Rob A E M Tollenaar, Ian Tomlinson, Diana Torres, Melissa A Troester, Thérèse Truong, Nadine Tung, Michael Untch, Celine M Vachon, Ans M W van den Ouweland, Lizet E van der Kolk, Elke M van Veen, Elizabeth J vanRensburg, Ana Vega, Barbara Wappenschmidt, Clarice R Weinberg, Jeffrey N Weitzel, Hans Wildiers, Robert Winqvist, Alicja Wolk, Xiaohong R Yang, Drakoulis Yannoukakos, Wei Zheng, Kristin K Zorn, Roger L Milne, Peter Kraft, Jacques Simard, Paul D P Pharoah, Kyriaki Michailidou, Antonis C Antoniou, Marjanka K Schmidt, Georgia Chenevix-Trench, Douglas F Easton, Nilanjan Chatterjee, Montserrat García-Closas

Affiliations

  1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, Bethesda, MD, USA.
  2. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  3. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  4. Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  5. Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  6. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  7. Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
  8. Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  9. Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  10. Department of Epidemiology, Genetic Epidemiology Research Institute, University of California, Irvine, Irvine, CA, USA.
  11. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  12. Department of Public Health Sciences and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
  13. Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  14. Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  15. Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  16. Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
  17. Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.
  18. Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  19. Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
  20. Division of Cancer Epidemiology, DKFZ, Heidelberg, Germany.
  21. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
  22. Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia.
  23. Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  24. Molecular Medicine Unit, Fundación Pública Galega de Medicina Xenómica, Santiago de Compostela, Spain.
  25. Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Santiago de Compostela, Spain.
  26. CIBERER, Santiago de Compostela, Spain.
  27. Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  28. Department of Oncology, Örebro University Hospital, Örebro, Sweden.
  29. N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
  30. Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
  31. Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.
  32. Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  33. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  34. Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  35. Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  36. Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, Milan, Italy.
  37. Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
  38. Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  39. iFIT Cluster of Excellence, University of Tübingen, Tübingen, Germany.
  40. German Cancer Consortium (DKTK), DKFZ, Heidelberg, Germany.
  41. Division of Preventive Oncology, DKFZ and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  42. Bioscience Department, Faculty of Medicine, Universidad de la Sabana, Chia, Colombia.
  43. Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  44. Department of Women's Health, University of Tübingen, Tübingen, Germany.
  45. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Ruhr University Bochum, Bochum, Germany.
  46. Molecular Epidemiology Group (C080), DKFZ, Heidelberg, Germany.
  47. Molecular Biology of Breast Cancer, University Women's Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany.
  48. Department of Medicine, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  49. Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester NIHR Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  50. Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
  51. Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.
  52. Department of Biology, University of Pisa, Pisa, Italy.
  53. Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
  54. Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  55. Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  56. Departments of Pediatrics and Medicine, Columbia University, New York, NY, USA.
  57. Centre for Medical Genetics, Ghent University, Ghent, Belgium.
  58. Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
  59. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  60. Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  61. Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
  62. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  63. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  64. Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
  65. Oncogenetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  66. Department of Medicine, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  67. Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK.
  68. Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK.
  69. Institute of Human Genetics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
  70. Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  71. David Geffen School of Medicine, Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
  72. Usher Institute of Population Health Sciences and Informatics, University of Edinburgh Medical School, Edinburgh, UK.
  73. Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  74. Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Athens, Greece.
  75. The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel.
  76. Genomic Medicine Group, Galician Foundation of Genomic Medicine, IDIS, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
  77. Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
  78. Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, USA.
  79. Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, MA, USA.
  80. Center for Bioinformatics and Functional Genomics and the Cedars-Sinai Genomics Core, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  81. Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.
  82. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.
  83. Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Victoria, Australia.
  84. Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, KS, USA.
  85. Department of Medicine, McGill University, Montréal, Québec, Canada.
  86. Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montréal, Québec, Canada.
  87. Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
  88. Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.
  89. Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  90. Cancer and Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University of Paris-Saclay, Paris, France.
  91. Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center ER-EMN, Erlangen, Germany.
  92. Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  93. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  94. Waukesha Memorial Hospital Pro Health Care, Waukesha, WI, USA.
  95. Department of Oncology, Södersjukhuset, Stockholm, Sweden.
  96. Molecular Genetics of Breast Cancer, DKFZ, Heidelberg, Germany.
  97. Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  98. Nightingale Breast Screening Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  99. Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  100. Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  101. Saarland Cancer Registry, Saarbrücken, Germany.
  102. Division of Cancer Sciences, University of Manchester, Manchester, UK.
  103. Center for Medical Genetics, NorthShore University HealthSystem, Evanston, IL, USA.
  104. N.N. Petrov Institute of Oncology, St. Petersburg, Russia.
  105. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  106. Clinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  107. Research Centre for Genetic Engineering and Biotechnology 'Georgi D. Efremov', Macedonian Academy of Sciences and Arts, Skopje, Republic of Macedonia.
  108. Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
  109. Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  110. Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
  111. State Research Institute Center for Innovative Medicine, Vilnius, Lithuania.
  112. Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  113. Department of Medicine, Division of Oncology, Stanford Cancer Institute, School of Medicine, Stanford University, Stanford, CA, USA.
  114. Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  115. Faculty of Medicine, University of Heidelberg, Heidelberg, Germany.
  116. David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, CA, USA.
  117. Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  118. Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia.
  119. Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  120. Department of Internal Medicine, Evangelische Kliniken Bonn, Johanniter Krankenhaus, Bonn, Germany.
  121. Department of Surgical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  122. Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
  123. Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  124. Department of Surgical Pathology, Zealand University Hospital, Slagelse, Denmark.
  125. VIB Center for Cancer Biology, VIB, Leuven, Belgium.
  126. Laboratory of Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium.
  127. Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  128. Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  129. Université Paris Sorbonne Cité, INSERM UMR-S1147, Paris, France.
  130. Molecular Diagnostic Unit, Hereditary Cancer Program, Bellvitge Biomedical Research Institute (IDIBELL), Catalan Institute of Oncology (ICO), CIBERONC, Barcelona, Spain.
  131. Ss. Cyril and Methodius University in Skopje, Medical Faculty, University Clinic of Radiotherapy and Oncology, Skopje, Republic of North Macedonia.
  132. Genetic Epidemiology of Cancer Team, INSERM U900, Paris, France.
  133. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
  134. Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
  135. Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie Cancer Center, Oncology Institute, Warsaw, Poland.
  136. University of Tübingen, Tübingen, Germany.
  137. Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland.
  138. Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.
  139. Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland.
  140. Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  141. Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA.
  142. Immunology and Molecular Oncology Unit, Veneto Institute of Oncology (IOV)-IRCCS, Padua, Italy.
  143. Department of Anatomical Pathology, The Alfred Hospital, Melbourne, Victoria, Australia.
  144. Genetic Epidemiology of Cancer Team, INSERM U900, Institut Curie, PSL University, Mines ParisTech, Paris, France.
  145. Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
  146. MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK.
  147. NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA.
  148. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
  149. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  150. Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
  151. Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  152. Latvian Biomedical Research and Study Centre, Riga, Latvia.
  153. Department of Family Medicine and Public Health, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
  154. Clinical Genetics Research Laboratory, Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  155. Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  156. Center for Clinical Cancer Genetics, The University of Chicago, Chicago, IL, USA.
  157. Department of Clinical Pathology, University of Melbourne, Melbourne, Victoria, Australia.
  158. Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.
  159. Clinical Genetics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  160. Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK.
  161. Unit of Medical Genetics, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy.
  162. Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
  163. Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
  164. Genome Diagnostics Program, IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
  165. Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
  166. Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  167. Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  168. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, INT, Milan, Italy.
  169. Adult Cancer Program, Lowy Cancer Research Centre, University of NSW Sydney, Sydney, New South Wales, Australia.
  170. School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, Sydney, New South Wales, Australia.
  171. The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
  172. Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
  173. Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH&RC), Lahore, Pakistan.
  174. Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
  175. Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain.
  176. Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
  177. Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  178. Institute of Pathology, Staedtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  179. Department of Oncology, University Hospital of Larissa, Larissa, Greece.
  180. Prevent Breast Cancer Centre and Nightingale Breast Screening Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  181. Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
  182. Research Oncology, Guy's Hospital, King's College London, London, UK.
  183. Cancer Genetics and Prevention Program, University of California, San Francisco, San Francisco, CA, USA.
  184. NCT, University Hospital and DKFZ, Heidelberg, Germany.
  185. Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  186. Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas City, KS, USA.
  187. Department of Health Sciences Research, Mayo Clinic College of Medicine, Jacksonville, FL, USA.
  188. Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  189. Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  190. Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Québec, Canada.
  191. Population Oncology, BC Cancer, Vancouver, British Columbia, Canada.
  192. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  193. Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia.
  194. Department of Genetics, INSERM U830, Institut Curie, Paris Descartes Sorbonne-Paris Cité University, Paris, France.
  195. Division of Breast Cancer Research, The Institute of Cancer Research, London, UK.
  196. National Human Genome Research Institute, National Cancer Institute, Bethesda, MD, USA.
  197. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  198. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  199. Faculty of Medicine, University of Southampton, Southampton, UK.
  200. Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
  201. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
  202. Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  203. Department of Medicine, Magee-Womens Hospital, School of Medicine, University of Pittsburgh , Pittsburgh, PA, USA.
  204. Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Québec, Canada.
  205. Department of Medical Genetics, National Institute for Health Research, Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  206. Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
  207. Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
  208. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  209. Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.
  210. Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
  211. Department of Epidemiology, Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  212. Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  213. Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin, Germany.
  214. Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
  215. Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
  216. Department of Genetics, University of Pretoria, Pretoria, South Africa.
  217. Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Durham, NC, USA.
  218. Clinical Cancer Genomics, City of Hope, Duarte, CA, USA.
  219. Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.
  220. Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland.
  221. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  222. Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
  223. Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  224. Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  225. Cyprus School of Molecular Medicine, Nicosia, Cyprus.
  226. Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  227. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. [email protected].
  228. Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA. [email protected].

PMID: 32424353 PMCID: PMC7808397 DOI: 10.1038/s41588-020-0609-2

Abstract

Breast cancer susceptibility variants frequently show heterogeneity in associations by tumor subtype

References

  1. Michailidou, K. et al. Association analysis identifies 65 new breast cancer risk loci. Nature 551, 92–94 (2017). - PubMed
  2. Milne, R. L. et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nat. Genet. 49, 1767–1778 (2017). - PubMed
  3. Garcia-Closas, M. et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat. Genet. 45, 392–398 (2013). - PubMed
  4. Zhang, H. et al. A mixed-model approach for powerful testing of genetic associations with cancer risk incorporating tumor characteristics. Biostatistics https://doi.org/10.1093/biostatistics/kxz065 (2020). - PubMed
  5. Michailidou, K. et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet. 45, 353–361 (2013). - PubMed
  6. Michailidou, K. et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat. Genet. 47, 373–380 (2015). - PubMed
  7. Dempster, A. P., Laird, N. M. & Rubin, D. B. Maximum likelihood from incomplete data via the EM algorithm. J. R. Stat. Soc. B 39, 1–38 (1977). - PubMed
  8. Curigliano, G. et al. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann. Oncol. 28, 1700–1712 (2017). - PubMed
  9. Spurdle, A. B. et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Res. 16, 3419 (2014). - PubMed
  10. Phelan, C. M. et al. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nat. Genet. 49, 680–691 (2017). - PubMed
  11. Stacey, S. N. et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat. Genet. 43, 1098–1103 (2011). - PubMed
  12. Pellacani, D. et al. Analysis of normal human mammary epigenomes reveals cell-specific active enhancer states and associated transcription factor networks. Cell Rep. 17, 2060–2074 (2016). - PubMed
  13. Beesley, J. et al. Chromatin interactome mapping at 139 independent breast cancer risk signals. Genome Biol. 21, 8 (2020). - PubMed
  14. Fachal, L. et al. Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes. Nat. Genet. 52, 56–73 (2020). - PubMed
  15. Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47–54 (2016). - PubMed
  16. Ferreira, M. A. et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nat. Commun. 10, 1741 (2019). - PubMed
  17. Wu, L. et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nat. Genet. 50, 968–978 (2018). - PubMed
  18. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015). - PubMed
  19. Bulik-Sullivan, B. K. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015). - PubMed
  20. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015). - PubMed
  21. Ahearn, T. U. et al. Common breast cancer risk loci predispose to distinct tumor subtypes. Preprint at bioRxiv https://www.biorxiv.org/content/10.1101/733402v1 (2019). - PubMed
  22. Mavaddat, N. et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am. J. Hum. Genet. 104, 21–34 (2019). - PubMed
  23. Lin, D. Y. & Sullivan, P. F. Meta-analysis of genome-wide association studies with overlapping subjects. Am. J. Hum. Genet. 85, 862–872 (2009). - PubMed
  24. Chatterjee, N. A two-stage regression model for epidemiological studies with multivariate disease classification data. J. Am. Stat. Assoc. 99, 127–138 (2004). - PubMed
  25. Anderson, W. F., Rosenberg, P. S., Prat, A., Perou, C. M. & Sherman, M. E. How many etiological subtypes of breast cancer: two, three, four, or more? J. Natl. Cancer Inst. 106, dju165 (2014). - PubMed
  26. Barnes, D. R. et al. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet. Epidemiol. 36, 274–291 (2012). - PubMed
  27. Antoniou, A. C. et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat. Genet. 42, 885–892 (2010). - PubMed
  28. Mavaddat, N. et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol. Biomarkers Prev. 21, 134–147 (2012). - PubMed
  29. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010). - PubMed
  30. Hendricks, A. E., Dupuis, J., Logue, M. W., Myers, R. H. & Lunetta, K. L. Correction for multiple testing in a gene region. Eur. J. Hum. Genet. 22, 414–418 (2014). - PubMed
  31. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995). - PubMed
  32. Udler, M. S., Tyrer, J. & Easton, D. F. Evaluating the power to discriminate between highly correlated SNPs in genetic association studies. Genet. Epidemiol. 34, 463–468 (2010). - PubMed
  33. Wellcome Trust Case Control Consortiumet al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44, 1294–1301 (2012). - PubMed
  34. Pharoah, P. D. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat. Genet. 31, 33–36 (2002). - PubMed
  35. Visscher, P. M., Hill, W. G. & Wray, N. R. Heritability in the genomics era—concepts and misconceptions. Nat. Rev. Genet. 9, 255–266 (2008). - PubMed

Substances

MeSH terms

Publication Types

Grant support